A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

NCT00696384 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

418

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Azilsartan medoxomil
DRUG: Azilsartan medoxomil, with or without chlorthalidone and other non-angiotensin II receptor blocker antihypertensive medications.
DRUG: Placebo

Sponsor

Takeda